BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23083114)

  • 1. Effects of meloxicam and phenylbutazone on equine gastric mucosal permeability.
    D'Arcy-Moskwa E; Noble GK; Weston LA; Boston R; Raidal SL
    J Vet Intern Med; 2012; 26(6):1494-9. PubMed ID: 23083114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and safety of single and multiple oral doses of meloxicam in adult horses.
    Noble G; Edwards S; Lievaart J; Pippia J; Boston R; Raidal SL
    J Vet Intern Med; 2012; 26(5):1192-201. PubMed ID: 22860573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses.
    Monreal L; Sabaté D; Segura D; Mayós I; Homedes J
    Res Vet Sci; 2004 Apr; 76(2):145-9. PubMed ID: 14672858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS).
    Ricord M; Andrews FM; Yñiguez FJM; Keowen M; Garza F; Paul L; Chapman A; Banse HE
    Equine Vet J; 2021 Mar; 53(2):356-363. PubMed ID: 32697849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of oral meloxicam and phenylbutazone in 2 experimental pain models in the horse.
    ; Banse H; Cribb AE
    Can Vet J; 2017 Feb; 58(2):157-167. PubMed ID: 28216685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses.
    Reed SK; Messer NT; Tessman RK; Keegan KG
    Am J Vet Res; 2006 Mar; 67(3):398-402. PubMed ID: 16506899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally administered phenylbutazone causes oxidative stress in the equine gastric mucosa.
    Martínez Aranzales JR; Cândido de Andrade BS; Silveira Alves GE
    J Vet Pharmacol Ther; 2015 Jun; 38(3):257-64. PubMed ID: 25287371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylbutazone induces equine glandular gastric disease without decreasing prostaglandin E
    Pedersen SK; Cribb AE; Read EK; French D; Banse HE
    J Vet Pharmacol Ther; 2018 Apr; 41(2):239-245. PubMed ID: 29148168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effects of a combination of phenylbutazone and omeprazole on chronic lameness in Mongolian horses.
    Li Z; Du S; Wang X; Zhang L; Liu X; Fan Q; Yang H; Gao R
    Equine Vet J; 2024 May; 56(3):562-572. PubMed ID: 37337455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs.
    Smecuol E; Bai JC; Sugai E; Vazquez H; Niveloni S; Pedreira S; Mauriño E; Meddings J
    Gut; 2001 Nov; 49(5):650-5. PubMed ID: 11600467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effects of sucralfate and ranitidine in foals experimentally intoxicated with phenylbutazone.
    Geor RJ; Petrie L; Papich MG; Rousseaux C
    Can J Vet Res; 1989 Apr; 53(2):231-8. PubMed ID: 2713788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum protein expression in Equine Glandular Gastric Disease (EGGD) induced by phenylbutazone.
    Tesena P; Yingchutrakul Y; Roytrakul S; Wongtawan T; Angkanaporn K
    J Vet Med Sci; 2019 Mar; 81(3):418-424. PubMed ID: 30674748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: role of prostaglandins and inflammatory response.
    Villegas I; La Casa C; de la Lastra CA; Motilva V; Herrerías JM; Martín MJ
    Life Sci; 2004 Jan; 74(7):873-84. PubMed ID: 14659976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of meloxicam and phenylbutazone on renal responses to furosemide, dobutamine, and exercise in horses.
    Raidal SL; Hughes KJ; Charman AL; Nielsen SG; Phillips JK; Noble GK
    Am J Vet Res; 2014 Jul; 75(7):668-79. PubMed ID: 24959734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of top-dress formulations of suxibuzone and phenylbutazone on development of gastric ulcers in horses.
    Andrews FM; Reinemeyer CR; Longhofer SL
    Vet Ther; 2009; 10(3):113-20. PubMed ID: 20037965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic effects of Glycyrrhiza glabra root extract on phenylbutazone-induced Equine Glandular Gastric Disease (EGGD).
    Ahmadnejad M; Jalilzadeh-Amin G; Sykes BW
    J Equine Vet Sci; 2022 Nov; 118():104088. PubMed ID: 35908599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of phenylbutazone on inflammation and cartilage-derived biomarkers in equine joints with acute synovitis.
    de Grauw JC; van Loon JP; van de Lest CH; Brunott A; van Weeren PR
    Vet J; 2014 Jul; 201(1):51-6. PubMed ID: 24888681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses.
    MacAllister CG; Morgan SJ; Borne AT; Pollet RA
    J Am Vet Med Assoc; 1993 Jan; 202(1):71-7. PubMed ID: 8420909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of flunixin meglumine and meloxicam for post operative management of horses with strangulating small intestinal lesions.
    Naylor RJ; Taylor AH; Knowles EJ; Wilford S; Linnenkohl W; Mair TS; Johns IC
    Equine Vet J; 2014 Jul; 46(4):427-34. PubMed ID: 24372991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.
    Beretta C; Garavaglia G; Cavalli M
    Pharmacol Res; 2005 Oct; 52(4):302-6. PubMed ID: 15939622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.